vs

Side-by-side financial comparison of DONALDSON Co INC (DCI) and PACS Group, Inc. (PACS). Click either name above to swap in a different company.

PACS Group, Inc. is the larger business by last-quarter revenue ($1.4B vs $935.4M, roughly 1.5× DONALDSON Co INC). DONALDSON Co INC runs the higher net margin — 12.2% vs 4.4%, a 7.8% gap on every dollar of revenue. On growth, PACS Group, Inc. posted the faster year-over-year revenue change (18.4% vs 3.9%). Over the past eight quarters, PACS Group, Inc.'s revenue compounded faster (20.5% CAGR vs 3.3%).

Donaldson Company, Inc. is a filtration company engaged in the production and marketing of filtration products used in a variety of industry sectors, including commercial/industrial, aerospace, chemical, alternative energy (windmills), food & beverage, and pharmaceuticals. Also the company's research division, located in Minneapolis, Minn., participated in defense-related projects for various military applications.

DCI vs PACS — Head-to-Head

Bigger by revenue
PACS
PACS
1.5× larger
PACS
$1.4B
$935.4M
DCI
Growing faster (revenue YoY)
PACS
PACS
+14.5% gap
PACS
18.4%
3.9%
DCI
Higher net margin
DCI
DCI
7.8% more per $
DCI
12.2%
4.4%
PACS
Faster 2-yr revenue CAGR
PACS
PACS
Annualised
PACS
20.5%
3.3%
DCI

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DCI
DCI
PACS
PACS
Revenue
$935.4M
$1.4B
Net Profit
$113.9M
$59.7M
Gross Margin
35.2%
Operating Margin
16.0%
7.0%
Net Margin
12.2%
4.4%
Revenue YoY
3.9%
18.4%
Net Profit YoY
15.1%
3022.5%
EPS (diluted)
$0.97
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DCI
DCI
PACS
PACS
Q4 25
$935.4M
$1.4B
Q3 25
$980.7M
$1.3B
Q2 25
$940.1M
$1.3B
Q1 25
$870.0M
$1.3B
Q4 24
$900.1M
$1.1B
Q3 24
$935.4M
$1.0B
Q2 24
$927.9M
$981.4M
Q1 24
$876.7M
$934.3M
Net Profit
DCI
DCI
PACS
PACS
Q4 25
$113.9M
$59.7M
Q3 25
$114.3M
$52.4M
Q2 25
$57.8M
$51.0M
Q1 25
$95.9M
$28.5M
Q4 24
$99.0M
$1.9M
Q3 24
$109.7M
$15.6M
Q2 24
$113.5M
$-10.9M
Q1 24
$98.7M
$49.1M
Gross Margin
DCI
DCI
PACS
PACS
Q4 25
35.2%
Q3 25
34.5%
Q2 25
34.2%
Q1 25
35.2%
Q4 24
35.5%
Q3 24
35.8%
17.1%
Q2 24
35.6%
22.3%
Q1 24
35.2%
21.2%
Operating Margin
DCI
DCI
PACS
PACS
Q4 25
16.0%
7.0%
Q3 25
15.5%
6.4%
Q2 25
9.3%
6.2%
Q1 25
14.4%
3.8%
Q4 24
14.5%
1.7%
Q3 24
15.6%
2.2%
Q2 24
15.5%
0.1%
Q1 24
14.8%
8.6%
Net Margin
DCI
DCI
PACS
PACS
Q4 25
12.2%
4.4%
Q3 25
11.7%
3.9%
Q2 25
6.1%
3.9%
Q1 25
11.0%
2.2%
Q4 24
11.0%
0.2%
Q3 24
11.7%
1.5%
Q2 24
12.2%
-1.1%
Q1 24
11.3%
5.3%
EPS (diluted)
DCI
DCI
PACS
PACS
Q4 25
$0.97
$0.42
Q3 25
$0.97
$0.32
Q2 25
$0.48
$0.31
Q1 25
$0.79
$0.17
Q4 24
$0.81
$-0.03
Q3 24
$0.90
$0.10
Q2 24
$0.92
$-0.07
Q1 24
$0.81
$0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DCI
DCI
PACS
PACS
Cash + ST InvestmentsLiquidity on hand
$210.7M
$197.0M
Total DebtLower is stronger
$671.5M
$353.2M
Stockholders' EquityBook value
$1.5B
$946.8M
Total Assets
$3.0B
$5.6B
Debt / EquityLower = less leverage
0.44×
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DCI
DCI
PACS
PACS
Q4 25
$210.7M
$197.0M
Q3 25
$180.4M
$355.7M
Q2 25
$178.5M
$294.2M
Q1 25
$189.1M
$287.5M
Q4 24
$221.2M
$157.7M
Q3 24
$232.7M
$49.5M
Q2 24
$223.7M
$73.4M
Q1 24
$193.8M
$81.2M
Total Debt
DCI
DCI
PACS
PACS
Q4 25
$671.5M
$353.2M
Q3 25
$630.4M
Q2 25
$638.8M
Q1 25
$514.7M
Q4 24
$538.6M
$411.9M
Q3 24
$483.4M
Q2 24
$481.8M
Q1 24
$352.0M
Stockholders' Equity
DCI
DCI
PACS
PACS
Q4 25
$1.5B
$946.8M
Q3 25
$1.5B
$871.3M
Q2 25
$1.5B
$806.8M
Q1 25
$1.5B
$750.2M
Q4 24
$1.5B
$709.6M
Q3 24
$1.5B
$660.0M
Q2 24
$1.5B
$572.1M
Q1 24
$1.4B
$128.0M
Total Assets
DCI
DCI
PACS
PACS
Q4 25
$3.0B
$5.6B
Q3 25
$3.0B
$5.6B
Q2 25
$3.0B
$5.5B
Q1 25
$3.0B
$5.5B
Q4 24
$3.0B
$5.2B
Q3 24
$2.9B
$4.5B
Q2 24
$2.9B
$3.9B
Q1 24
$2.8B
$3.9B
Debt / Equity
DCI
DCI
PACS
PACS
Q4 25
0.44×
0.37×
Q3 25
0.43×
Q2 25
0.44×
Q1 25
0.33×
Q4 24
0.35×
0.58×
Q3 24
0.32×
Q2 24
0.32×
Q1 24
0.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DCI
DCI
PACS
PACS
Operating Cash FlowLast quarter
$125.4M
$-3.4M
Free Cash FlowOCF − Capex
$111.2M
FCF MarginFCF / Revenue
11.9%
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
1.10×
-0.06×
TTM Free Cash FlowTrailing 4 quarters
$403.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DCI
DCI
PACS
PACS
Q4 25
$125.4M
$-3.4M
Q3 25
$167.8M
$204.8M
Q2 25
$87.7M
$52.6M
Q1 25
$90.4M
$150.2M
Q4 24
$72.9M
$64.6M
Q3 24
$126.0M
$209.2M
Q2 24
$141.5M
$34.8M
Q1 24
$87.0M
$58.8M
Free Cash Flow
DCI
DCI
PACS
PACS
Q4 25
$111.2M
Q3 25
$147.5M
Q2 25
$73.0M
Q1 25
$71.5M
Q4 24
$47.9M
Q3 24
$106.2M
Q2 24
$120.2M
Q1 24
$65.7M
FCF Margin
DCI
DCI
PACS
PACS
Q4 25
11.9%
Q3 25
15.0%
Q2 25
7.8%
Q1 25
8.2%
Q4 24
5.3%
Q3 24
11.4%
Q2 24
13.0%
Q1 24
7.5%
Capex Intensity
DCI
DCI
PACS
PACS
Q4 25
1.5%
Q3 25
2.1%
Q2 25
1.6%
Q1 25
2.2%
Q4 24
2.8%
Q3 24
2.1%
Q2 24
2.3%
Q1 24
2.4%
Cash Conversion
DCI
DCI
PACS
PACS
Q4 25
1.10×
-0.06×
Q3 25
1.47×
3.91×
Q2 25
1.52×
1.03×
Q1 25
0.94×
5.28×
Q4 24
0.74×
33.78×
Q3 24
1.15×
13.39×
Q2 24
1.25×
Q1 24
0.88×
1.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DCI
DCI

Aftermarket Products$447.1M48%
Industrial Filtration Solutions Products$222.6M24%
Off Road Products$86.5M9%
Life Sciences Segment$80.0M9%
Other$39.1M4%
Aerospace And Defense Products$37.1M4%
On Road Products$23.0M2%

PACS
PACS

Segment breakdown not available.

Related Comparisons